Masimo Radical® with SET Better than Nellcor N-600 with OxiMax, GE TruSat at Measuring SpO2 during Motion, Low Perfusion June 25, 2012 Masimo (NASDAQ: MASI) announced today a new study in the Journal ...

IRVINE, CA--(Marketwired - May 6, 2014) - Masimo (NASDAQ: MASI) today announced that the largest-ever study of newborn screening for congenital heart disease (CHD) was published online by The Lancet.

Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...

The Masimo MX-5 circuit board enables full functionality of Masimo rainbow(R) Pulse CO-Oximetry(TM) measurements at a fraction of the power consumption of prior rainbow(R) boards. Click here for ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...

The authors stated that both PVI and SVV are "much more valuable for prediction of volume responsiveness than CVP" and that PVI "is of high value, especially regarding sensitivity and negative ...

Noting that OSA “can only be reliably diagnosed using multichannel sleep studies, which are expensive, demanding for families and only available in specialist centres,” Dr. Hill and colleagues at the ...

About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...

IRVINE, Calif., June 25, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in the Journal of Clinical Anesthesia demonstrates the Masimo Radical® with Masimo SET® pulse oximetry ...

IRVINE, Calif., Aug. 7, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in the Journal of Anesthesia demonstrates that for fluid responsiveness assessment, Masimo's noninvasive ...